ArticleStem cell research & therapy2025
Engineering chitosan fibers with MSC-exosome cargo: a clinically translatable multifunctional dressing for regenerative therapy in infected wound management.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundChronic wound healing is a complex clinical challenge, particularly due to microbial colonization and the deactivation of repair cells. This study presents an innovative strategy involving the combination of micron-scale chitosan fibers with exosomes, aiming to develop a new type of dressing with multiple functionalities, including dynamic exudate management, antimicrobial properties, angiogenesis promotion, and tissue repair. The goal is to offer a cost-effective and clinically translatable treatment solution for infected wounds.
methodsChitosan (CS) fibers were prepared using a wet-spinning technique and subsequently modified through N-succinylation (NCS), followed by needle-punching to construct CS/NCS blended nonwoven fabrics. The physicochemical properties, water absorption/retention, and mechanical behavior of the materials were characterized using scanning electron microscopy (SEM), Fourier-transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD). Antibacterial and hemostatic performance were also evaluated. Mesenchymal stem cell-derived exosomes (MSC-EXO) were loaded onto the modified chitosan fibers via electrostatic assembly, forming the CS/NCS-EXO composite dressing, which was further tested in a rat model for infected wound repair.
resultsCompared to pure CS fibers and NCS fibers, the CS/NCS material demonstrated superior mechanical properties and moisture retention capacity in a wet state. Antibacterial assays showed that the CS/NCS material exhibited significantly enhanced antimicrobial activity against Staphylococcus aureus and Escherichia coli. Hemostatic experiments revealed that the CS/NCS group significantly shortened bleeding time and reduced blood loss. In the infected skin defect repair experiment, the CS/NCS-EXO group significantly accelerated wound healing, demonstrating the most prominent tissue repair effect, accompanied by abundant angiogenesis as confirmed by immunohistochemical staining.
conclusionThis study successfully developed a chitosan fiber-based exosome composite dressing system, which effectively coordinates infection control and tissue regeneration through a triple mechanism of "structural water-locking, mechanical adaptation, and bioactive synergy." This material provides a scalable solution for chronic wound management and shows promising clinical application prospects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.